Peek and Thomas also say the finding of a significant A1c reduction in patients on less intensive insulin regimens suggests the need for revision of the often-burdensome Medicare requirements that patients use multiple daily injections and conduct at least four fingerstick glucose measurements a day to qualify for reimbursement for CGM.